Bivalent single-cycle vaccines against respiratory diseases

• Unité de recherche: INNOSUISSE
• Numéro de projet: 119.403 IP-LS
• Titre du projet anglais: Bivalent single-cycle vaccines against respiratory diseases

Mots-clé (Anglais)

Life sciences, Biotechnology and processing

Résumé des résultats (Abstract) (Anglais)

Building on our SARS-CoV-2 single-cycle vaccine success, we aim to leverage this breakthrough by targeting additional respiratory viruses of clinical concern. For this, we will create bivalent vaccines and aim for high efficacy and intranasal delivery to offer potent immunity.